Entering text into the input field will update the search result below

Rigel Pharmaceuticals' (RIGL) CEO Raul Rodriguez on Q4 2020 Results - Earnings Call Transcript

Mar. 03, 2021 12:12 AM ETRigel Pharmaceuticals, Inc. (RIGL)
SA Transcripts profile picture
SA Transcripts

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q4 2020 Earnings Conference Call March 2, 2021 4:30 PM ET

Company Participants

Dolly Vance – Executive Vice President-Corporate Affairs and General Counsel

Raul Rodriguez – President and Chief Executive Officer

Dave Santos – Chief Commercial Officer

Wolfgang Dummer – Executive Vice President and Chief Medical Officer

Esteban Masuda – Executive Vice President-Research

Dean Schorno – Executive Vice President and Chief Financial Officer

Conference Call Participants

Yigal Nochomovitz – Citigroup

Eun Yang – Jefferies

Do Kim – BMO Capital Markets

Chris Raymond – Piper Sandler

Kristen Kluska – Cantor Fitzgerald

Emanuela Branchetti – H.C. Wainwright


Greetings, and welcome to the Rigel Pharmaceuticals’ Financial Conference Call for the Fourth Quarter and Year-End 2020. At this time, all participants are in a listen-only mode. [Operator Instructions] As a reminder, this conference is being recorded.

It’s now my pleasure to introduce our first speaker, Dolly Vance, who is Rigel’s Executive Vice President, Corporate Affairs and General Counsel. Thank you, Ms. Vance. You may begin.

Dolly Vance

Welcome to our fourth quarter and year-end 2020 financial results and business update conference call. The financial press release for the fourth quarter and year end was issued a short while ago and can be viewed along with the accompanying slides for this presentation in the News & Events section of our Investor Relations page on our website, www.rigel.com.

As a reminder, during today’s call, we may make forward-looking statements regarding our financial outlook, and our plans and timing for regulatory and product development. These statements are subject to risks and uncertainties that may cause actual results to differ from those forecasted. A description of these risks can be found in our most recent Annual Report on Form 10-K for the year ended December 31, 2020 on file with the SEC. Any forward-looking statements are made only as of

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.